India Dr Reddy's gets FDA nod for trandolapril tabs
MUMBAI, Aug 29 (Reuters) - Indian drugmaker Dr Reddy's Laboratories Ltd (REDY.BO: Quote, Profile, Research, Stock Buzz) (RDY.N: Quote, Profile, Research, Stock Buzz) has received approval from the U.S. Food and Drug Administration for trandolapril tablets, the regulator's website showed.
The drug is a generic version of Abbott Laboratories' (ABT.N: Quote, Profile, Research, Stock Buzz) Mavik tablets, indicated in the treatment of hypertension. (Reporting by Rina Chandran; Editing by Ranjit Gangadharan)
© Thomson Reuters 2008 All rights reserved
Ads by Career Builder
Revenue Cycle Management/ Healthcare
Details: Growing Healthcare Consultancy organization...seeks experienced Healthcare Revenue Cycle Management...initiatives to healthcare providers and payers...
Work from Home as a Healthcare Recruiter
Details: ...from Home as a Healthcare Recruiter Health...an international healthcare recruiting and...represents high-demand healthcare professionals and...
Regional Operations Director - Healthcare
Details: ...Operations Director - Healthcare This position will...skills/experience: Healthcare Multi-Site Management...benefits including the healthcare industry's most...
Lawson Analyst - Payroll for healthcare
Details: ...experience within a healthcare industry environment...Application Analyst, Healthcare Systems, Payroll...Analyst - Payroll for healthcare position, and have...
Attacks fuel India-Pakistan tensions
